Condition: Behavioral Variant of Frontotemporal Disorder (bvFTD) · Phenocopy Frontotemporal Dementia (phFTD) · Frontal Variant of Alzheimer Disease · Sponsor: Nantes University Hospital
Damages in frontal area present in neurodegenerative disease (frontotemporal degeneration, frontal variant of Alzheimer disease) and in psychiatric disease (bipolar disorder) can affect behavior and cognition including social cognition. Symptoms vary both quantitatively and qualitatively from disease to another and from person to person. It cannot be completely excluded that in some cases, factors of susceptibility such as premorbid personality traits lead to frontal fragility. The study will assess the relationship between premorbid profile using NEO-PI 3 inventory and cognitive and behavioral/psychobehavioral manifestations in patients with behavioral variant of frontotemporal disorder (bvFTD), phenocopy frontotemporal dementia (phFTD), frontal variant of Alzheimer disease, bipolar disorder characterized with frontal damages.
This description comes directly from the study's public registry record.
Claire BOUTOLEAU-BRETONNIERE, PH · 33 2 40 16 54 22 · claire.boutoleaubretonniere@chu-nantes.fr
Laetitia BARBIN · 33 2 40 16 59 42 · laetitia.barbin@chu-nantes.fr
Always discuss trial participation with your own doctor first.
| CHU de Nantes | Nantes, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06059313